Cargando…

Predictive value of the serum RASSF10 promoter methylation status in gastric cancer

BACKGROUND: This study aimed to investigate whether the detection of methylation in the promoter of the Ras association domain family 10 gene (RASSF10) in the serum of patients with gastric cancer (GC) by methylation-specific PCR (MSP) can be used as a diagnostic and prognostic indicator of GC. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yilin, Ma, Peng, Feng, Ying, Li, Peng, Wang, Hua, Guo, Yibing, Mao, Qinsheng, Xue, Wanjiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Clinical Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683939/ https://www.ncbi.nlm.nih.gov/pubmed/31119967 http://dx.doi.org/10.1177/0300060519848924

Ejemplares similares

Spondin 2 promotes the proliferation, migration and invasion of gastric cancer cells
por: Lu, Haoming, et al.
Publicado: (2019)

Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma
por: Feng, Ying, et al.
Publicado: (2018)

Outcomes of laparoscopic versus open total gastrectomy with D2 lymphadenectomy for gastric cancer: a systematic review and meta-analysis
por: Yang, Yongpu, et al.
Publicado: (2022)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

The Association of Ala133Ser Polymorphism and Methylation in Ras Association Domain Family 1A Gene With Unfavorable Prognosis of Hepatocellular Carcinoma
por: Feng, Ying, et al.
Publicado: (2015)

RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker
por: Jin, Yongshuai, et al.
Publicado: (2015)

RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2015)

Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer
por: Meng, Wei, et al.
Publicado: (2012)

Value of the level of methylation of RASSF1A and WIF-1 in tissue and serum in neoadjuvant chemotherapeutic assessment for advanced breast cancer
por: Han, Zhong-Hua, et al.
Publicado: (2017)

Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
por: Richter, Antje M., et al.
Publicado: (2016)

Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients
por: Deng, Qiu-Kui, et al.
Publicado: (2016)

Prognostic Role of RASSF1A, SOX17 and Wif-1 Promoter Methylation Status in Cell-Free DNA of Advanced Gastric Cancer Patients
por: Karamitrousis, Evangelos I., et al.
Publicado: (2021)

Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy
por: Sun, Xicai, et al.
Publicado: (2017)

Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China
por: Ye, Mei, et al.
Publicado: (2007)

The Role of RASSF1A Methylation in Cancer
por: Hesson, Luke B., et al.
Publicado: (2007)

Diagnostic value of RASSF1A methylation for breast cancer: a meta-analysis
por: Li, Mingyi, et al.
Publicado: (2019)

Tumor Suppressor RASSF1A Promoter: p53 Binding and Methylation
por: Tian, Yihao, et al.
Publicado: (2011)

Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer
por: Pimson, Charinya, et al.
Publicado: (2016)

Promoter Methylation Status and Expression Levels of RASSF1A Gene in Different Phases of Acute Lymphoblastic Leukemia (ALL)
por: Sohani, Mahsa, et al.
Publicado: (2021)

The Role of TSHR, PTEN and RASSF1A Promoters’ Methylation Status for Non-Invasive Detection of Papillary Thyroid Carcinoma
por: Klimaitė, Raimonda, et al.
Publicado: (2022)

RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis
por: Shou, Feiyan, et al.
Publicado: (2017)

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1
por: Volodko, Natalia, et al.
Publicado: (2016)

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
por: Hesson, Luke B, et al.
Publicado: (2009)

Promoter Methylation of RASSF1A Associates to Adult Secondary Glioblastomas and Pediatric Glioblastomas
por: Muñoz, Jorge, et al.
Publicado: (2012)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors
por: Malpeli, Giorgio, et al.
Publicado: (2011)

The Diagnosis Value of Promoter Methylation of UCHL1 in the Serum for Progression of Gastric Cancer
por: Wang, Gongping, et al.
Publicado: (2015)

Impact of RASSF1A gene methylation on the metastatic axillary nodal status in breast cancer patients
por: Jezkova, Eva, et al.
Publicado: (2017)

Association between RASSF1A Promoter Methylation and Ovarian Cancer: A Meta-Analysis
por: Shi, Hao, et al.
Publicado: (2013)

Clinical utility of RASSF1A methylation in human malignancies
por: Grawenda, A M, et al.
Publicado: (2015)

Methylation Dynamics of RASSF1A and Its Impact on Cancer
por: Malpeli, Giorgio, et al.
Publicado: (2019)

The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis
por: Reeves, Mark E., et al.
Publicado: (2013)

Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome
por: Xu, Jia, et al.
Publicado: (2012)

Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer
por: Guo, Qiang, et al.
Publicado: (2016)

Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals
por: Cao, Xue, et al.
Publicado: (2018)

Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA)
por: Zhan, Leyun, et al.
Publicado: (2017)

Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer
por: Gil, Eun Young, et al.
Publicado: (2017)

RASSF Family Proteins
por: Clark, Geoffrey J., et al.
Publicado: (2012)

Molecular basis for RASSF10/NPM/RNF2 feedback cascade–mediated regulation of gastric cancer cell proliferation
por: Lakshmi Ch, Naga Padma, et al.
Publicado: (2021)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rojjb9vs5jaacksus89fqf30uv